What dose of regular insulin is appropriate for a patient with a blood glucose level of hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Correction Insulin Dosing for Blood Glucose of 307 mg/dL

For a blood glucose of 307 mg/dL in a hospitalized or acute care setting, administer 10-15 units of regular insulin subcutaneously, based on standard correction scales that recommend 5 units for every 50 mg/dL above 150 mg/dL. 1

Immediate Dosing Algorithm

For non-DKA hyperglycemia with blood glucose of 307 mg/dL:

  • Calculate correction dose: Using the standard hospital protocol, give 5 units of regular insulin for every 50 mg/dL increment above 150 mg/dL 1

    • 307 mg/dL is approximately 150 mg/dL above target (150 mg/dL baseline)
    • This translates to 10-15 units of regular insulin subcutaneously 1
  • Alternative calculation using insulin sensitivity factor: If the patient's total daily insulin dose (TDD) is known, use the formula ISF = 1500 ÷ TDD to determine how much one unit will lower blood glucose 2

    • For example, if TDD is 50 units, then ISF = 30 mg/dL per unit
    • To lower from 307 to target of ~130 mg/dL (difference of 177 mg/dL), give approximately 6 units
    • However, this approach requires knowing the patient's established insulin regimen 2

Critical Considerations Before Administering

Rule out diabetic ketoacidosis (DKA) first:

  • If DKA is present (pH <7.3, bicarbonate <18 mEq/L, ketones present), do not use subcutaneous correction insulin alone 1
  • DKA requires continuous intravenous insulin infusion at 0.1 unit/kg/hour after an initial bolus of 0.15 units/kg 1

Assess the patient's insulin status:

  • For insulin-naive patients with blood glucose >300 mg/dL: A single correction dose is insufficient—these patients require initiation of a basal-bolus regimen with total daily dose of 0.3-0.5 units/kg 1, 3
  • For patients already on home insulin ≥0.6 units/kg/day: Reduce their total daily dose by 20% during hospitalization before adding correction insulin to prevent hypoglycemia 1, 3

Timing and Monitoring

  • Regular insulin should be administered subcutaneously every 4-6 hours as needed for correction of hyperglycemia 1
  • Rapid-acting insulin analogs can be given every 4 hours as an alternative, with faster onset but similar correction effect 1
  • Recheck blood glucose in 4-6 hours after regular insulin administration to assess response 1

Common Pitfalls to Avoid

Never rely on correction insulin alone:

  • Sliding scale insulin monotherapy is strongly discouraged and associated with poor glycemic control 1, 3
  • A blood glucose of 307 mg/dL indicates the need for a scheduled basal-bolus regimen, not just correction doses 1, 3

Avoid insulin stacking:

  • Do not administer another correction dose within 4-6 hours of the previous regular insulin dose, as the prior dose may still be active 2, 1
  • Regular insulin has a duration of action of 6-8 hours after subcutaneous injection 1

Reduce doses in high-risk patients:

  • For patients >65 years old, with renal failure, or poor oral intake, use lower correction doses (maximum 10-15 units rather than 20 units for glucose of 300 mg/dL) 1, 3

Transition to Scheduled Insulin Therapy

After giving correction insulin, establish a basal-bolus regimen:

  • Calculate total daily insulin needs as 0.3-0.5 units/kg for patients with severe hyperglycemia 1, 3
  • Give 50% as basal insulin (once daily long-acting) and 50% as prandial insulin (divided among three meals) 1, 3
  • Continue correction insulin every 4-6 hours as needed in addition to the scheduled regimen 1, 3

References

Guideline

Hyperglycemia Management in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Dose Adjustment for Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the recommended adjustments to Lantus (insulin glargine) dose, carb ratio, and correction scale for a patient with hyperglycemia?
What is the recommended approach to starting an insulin regimen for a patient newly diagnosed with type 2 diabetes mellitus (T2DM)?
What are the treatment options for a patient with hyperglycemia, currently on metformin (biguanide) 1000mg, Farxiga (dapagliflozin) 10mg, and Mounjaro (tirzepatide) 7.5mg monthly, who cannot increase Mounjaro due to significant weight loss and declines all forms of insulin, with a hemoglobin A1C (HbA1C) level of 9.8%?
What should the Lantus (insulin glargine) dose, carb coverage, and correction scale be for a 49-year-old male with type 2 diabetes, previously on Metformin (metformin hydrochloride), with a history of Diabetic Ketoacidosis (DKA) and current Hyperglycemia (A1C 12.3%)?
What is the appropriate initial insulin dose for a patient with type 2 diabetes mellitus (T2DM) and severe hyperglycemia?
What is the recommended treatment approach for an adult patient with a history of depression using Auvelity (dextromethadone/bupropion)?
What is the appropriate diagnostic and treatment approach for an adult patient with consistently elevated Alanine Transaminase (ALT) and erythrocytosis?
What adjustments should be made to the medication regimen of a 60-year-old male with uncontrolled hypertension, dyslipidemia, and gouty arthritis, who is currently taking allopurinol (100mg once daily), telmisartan (40mg once daily), and has lab results indicating impaired renal function and hyperuricemia?
What are the causes of metabolic acidosis in individuals, particularly those with diabetes, kidney disease, or a history of severe illness?
What is the next best step for a patient with persistent anxiety despite taking Buspar (buspirone) 30mg twice a day (BID)?
What is the recommended treatment for an otherwise healthy adult with mild to moderate influenza (flu) symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.